284 related articles for article (PubMed ID: 25881202)
1. PPARα agonists inhibit inflammatory activation of macrophages through upregulation of β-defensin 1.
Ann SJ; Chung JH; Park BH; Kim SH; Jang J; Park S; Kang SM; Lee SH
Atherosclerosis; 2015 Jun; 240(2):389-97. PubMed ID: 25881202
[TBL] [Abstract][Full Text] [Related]
2. A novel PPARα agonist propane-2-sulfonic acid octadec-9-enyl-amide inhibits inflammation in THP-1 cells.
Zhao Y; Yan L; Luo XM; Peng L; Guo H; Jing Z; Yang LC; Hu R; Wang X; Huang XF; Wang YQ; Jin X
Eur J Pharmacol; 2016 Oct; 788():104-112. PubMed ID: 27318324
[TBL] [Abstract][Full Text] [Related]
3. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.
Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH
J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289
[TBL] [Abstract][Full Text] [Related]
4. PPARα agonist fenofibrate attenuates TNF-α-induced CD40 expression in 3T3-L1 adipocytes via the SIRT1-dependent signaling pathway.
Wang W; Lin Q; Lin R; Zhang J; Ren F; Zhang J; Ji M; Li Y
Exp Cell Res; 2013 Jun; 319(10):1523-33. PubMed ID: 23603572
[TBL] [Abstract][Full Text] [Related]
5. PPARalpha activator fenofibrate modulates angiotensin II-induced inflammatory responses in vascular smooth muscle cells via the TLR4-dependent signaling pathway.
Ji YY; Liu JT; Liu N; Wang ZD; Liu CH
Biochem Pharmacol; 2009 Nov; 78(9):1186-97. PubMed ID: 19576184
[TBL] [Abstract][Full Text] [Related]
6. Modulation of LPS-mediated inflammation by fenofibrate via the TRIF-dependent TLR4 signaling pathway in vascular smooth muscle cells.
Ji Y; Wang Z; Li Z; Liu J
Cell Physiol Biochem; 2010; 25(6):631-40. PubMed ID: 20511708
[TBL] [Abstract][Full Text] [Related]
7. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
[TBL] [Abstract][Full Text] [Related]
8. Regulation of peroxisome proliferator-activated receptor-alpha expression during lung inflammation.
Becker J; Delayre-Orthez C; Frossard N; Pons F
Pulm Pharmacol Ther; 2008; 21(2):324-30. PubMed ID: 17897854
[TBL] [Abstract][Full Text] [Related]
9. CXCL9 and CXCL11 chemokines modulation by peroxisome proliferator-activated receptor-alpha agonists secretion in Graves' and normal thyrocytes.
Antonelli A; Ferrari SM; Frascerra S; Pupilli C; Mancusi C; Metelli MR; Orlando C; Ferrannini E; Fallahi P
J Clin Endocrinol Metab; 2010 Dec; 95(12):E413-20. PubMed ID: 20810571
[TBL] [Abstract][Full Text] [Related]
10. Effect of PPARalpha activation of macrophages on the secretion of inflammatory cytokines in cultured adipocytes.
Murakami K; Bujo H; Unoki H; Saito Y
Eur J Pharmacol; 2007 Apr; 561(1-3):206-13. PubMed ID: 17320860
[TBL] [Abstract][Full Text] [Related]
11. Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARα-independent mechanisms.
Yamasaki D; Kawabe N; Nakamura H; Tachibana K; Ishimoto K; Tanaka T; Aburatani H; Sakai J; Hamakubo T; Kodama T; Doi T
Eur J Cell Biol; 2011 Aug; 90(8):657-64. PubMed ID: 21514001
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory properties of a dual PPARgamma/alpha agonist muraglitazar in in vitro and in vivo models.
Paukkeri EL; Leppänen T; Lindholm M; Yam MF; Asmawi MZ; Kolmonen A; Aulaskari PH; Moilanen E
Arthritis Res Ther; 2013 Apr; 15(2):R51. PubMed ID: 23594962
[TBL] [Abstract][Full Text] [Related]
13. Agonists for the peroxisome proliferator-activated receptor-alpha and the retinoid X receptor inhibit inflammatory responses of microglia.
Xu J; Storer PD; Chavis JA; Racke MK; Drew PD
J Neurosci Res; 2005 Aug; 81(3):403-11. PubMed ID: 15968640
[TBL] [Abstract][Full Text] [Related]
14. Negatively regulating TLR4/NF-κB signaling via PPARα in endotoxin-induced uveitis.
Shen W; Gao Y; Lu B; Zhang Q; Hu Y; Chen Y
Biochim Biophys Acta; 2014 Jul; 1842(7):1109-20. PubMed ID: 24717912
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effect of fenofibrate on angiotensin II-induced toll-like receptor 4 expression, myeloperoxidase activity and expression in RAW264.7 cells].
Ji YY; Wang ZD; Liu JT; Liu N
Yao Xue Xue Bao; 2009 May; 44(5):462-7. PubMed ID: 19618719
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-12 gene regulation by a PPAR alpha agonist in human monocyte-derived macrophages.
Souissi IJ; Billiet L; Cuaz-Pérolin C; Slimane MN; Rouis M
Exp Cell Res; 2008 Nov; 314(18):3405-14. PubMed ID: 18823978
[TBL] [Abstract][Full Text] [Related]
17. FABP4 inhibition suppresses PPARγ activity and VLDL-induced foam cell formation in IL-4-polarized human macrophages.
Boss M; Kemmerer M; Brüne B; Namgaladze D
Atherosclerosis; 2015 Jun; 240(2):424-30. PubMed ID: 25897794
[TBL] [Abstract][Full Text] [Related]
18. In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence.
Jackson A; Bagdas D; Muldoon PP; Lichtman AH; Carroll FI; Greenwald M; Miles MF; Damaj MI
Neuropharmacology; 2017 May; 118():38-45. PubMed ID: 28279662
[TBL] [Abstract][Full Text] [Related]
19. The protective effect of fenofibrate against TNF-α-induced CD40 expression through SIRT1-mediated deacetylation of NF-κB in endothelial cells.
Wang W; Bai L; Qiao H; Lu Y; Yang L; Zhang J; Lin R; Ren F; Zhang J; Ji M
Inflammation; 2014 Feb; 37(1):177-85. PubMed ID: 24022598
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]